Skip to main content
Normal View

Hospital Waiting Lists

Dáil Éireann Debate, Thursday - 25 November 2021

Thursday, 25 November 2021

Questions (332)

Emer Higgins

Question:

332. Deputy Emer Higgins asked the Minister for Health if his attention has been drawn to a group (details supplied); his plans to meet with the group; the current actions being taken to lessen the waiting times for children awaiting surgery for spina bifida; and if he will make a statement on the matter. [58079/21]

View answer

Written answers (Question to Health)

I sincerely regret that children can experience a long waiting time for hospital appointments and treatment, and I remain conscious of the burden that this places on them and their families. My priority as Minister for Health, and that of this Government, is to improve waiting times for all patients accessing hospital treatment. Reducing the paediatric orthopaedic waiting list remains a priority within that.

This Government remains committed to improving access to hospital appointments and procedures. For 2022 an additional allocation of €250 million, comprised of €200 million to the HSE and €50 million to the National Treatment Purchase Fund has been provided in respect of work to reduce hospital and community waiting lists. The €250 million will be used to fund additional activity in both the public and private sectors. The €50 million additional funding provided to the NTPF brings its total allocation for 2022 to €150 million, and as a consequence there will be a budget of €350 million available to support vital initiatives to improve access to acute hospitals and community health services.

In addition, my Department, the HSE and the National Treatment Purchase Fund are also working on a Multi Annual Waiting List Plan to reduce waiting lists. This process will be overseen by a Ministerial Taskforce, chaired by the Secretary General of my Department and includes representatives from the HSE and National Treatment Purchase Fund. The plan will be informed by the lessons learned from the successful Vaccine Taskforce.

Top
Share